Hims & Hers Health, Inc. (HIMS) vs Ligand Pharmaceuticals Incorporated (LGND)
A side-by-side comparison of Hims & Hers Health, Inc. and Ligand Pharmaceuticals Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HIMS
Hims & Hers Health, Inc.
$29.17HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT
LGND
Ligand Pharmaceuticals Incorporated
$294.61HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT
Total return — HIMS vs LGND
growth of $100 · dividends reinvested · last 7yHIMS +202.8% (+17.1%/yr)LGND +470.1% (+28.2%/yr)LGND compounded faster over this window
HIMS LGND
HIMS vs LGND: by the numbers
- •HIMS is the larger company ($6.51B vs $5.90B market cap).
- •LGND is profitable (67.88% net margin) while HIMS runs a net loss (-5.51%).
- •HIMS grew revenue faster over the past five years (67.47% vs 2.92% CAGR).
Metrics side by side
Valuation
| Metric | HIMS | LGND |
|---|---|---|
| P/E ratio | N/A | 31.51 |
| Forward P/E | N/A | 31.66 |
| P/S ratio | 2.52 | 20.32 |
| P/B ratio | 20.08 | 6.10 |
| EV / EBITDA | N/A | 44.67 |
| FCF yield | 1.38% | 2.22% |
Profitability
| Metric | HIMS | LGND |
|---|---|---|
| Gross margin | 73.84% | 98.58% |
| Operating margin | 4.50% | 17.61% |
| Net margin | -5.51% | 67.88% |
| ROE | -43.83% | 20.38% |
| ROIC | -4.30% | 3.91% |
Growth (annualized)
| Metric | HIMS | LGND |
|---|---|---|
| Revenue CAGR (5Y) | 67.47% | 2.92% |
| FCF CAGR (5Y) | N/A | -0.49% |
| Total return CAGR (5Y) | 32.23% | 30.72% |
Frequently asked
- Which has grown faster, HIMS or LGND?
- Over the past five years, HIMS grew revenue faster — HIMS at a 67.47% CAGR versus LGND at 2.92%.
- Is HIMS or LGND more profitable?
- LGND runs the higher net margin — HIMS at -5.51% versus LGND at 67.88%.
- How have HIMS and LGND total returns compared?
- Over the past 5 years, HIMS delivered 32.23% and LGND delivered 30.72% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Ligand Pharmaceuticals P/E ratioHims & Hers Health ROELigand Pharmaceuticals ROEHims & Hers Health operating marginLigand Pharmaceuticals operating marginHims & Hers Health revenue growthLigand Pharmaceuticals revenue growthHims & Hers Health free cash flowLigand Pharmaceuticals free cash flow
Hims & Hers Health & Ligand Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.